| Revision as of 00:26, 16 December 2024 editVortexjourney754 (talk | contribs)158 editsmNo edit summaryTag: Visual edit← Previous edit | Revision as of 17:23, 16 December 2024 edit undoVortexjourney754 (talk | contribs)158 editsmNo edit summaryTag: Visual editNext edit → | ||
| Line 15: | Line 15: | ||
| }} | }} | ||
| '''Bias Capital, LLC''' (commonly known as '''Bias Capital''') is an American ] that invests in both early-stage ] and established ]. | '''Bias Capital, LLC''' (commonly known as '''Bias Capital''') is an American ] that invests in both early-stage ] and established ]. In addition to its primary investments, the firm operates an ], offering individual investors the opportunity to access and participate in select investment opportunities. | ||
| The firm was established to integrate diversity as a core principle in its investment strategy and operations. Rather than treating diversity as a separate initiative, Bias Capital incorporates it into all aspects of its decision-making process. | The firm was established to integrate diversity as a core principle in its investment strategy and operations. Rather than treating diversity as a separate initiative, Bias Capital incorporates it into all aspects of its decision-making process. | ||
| Line 25: | Line 25: | ||
| == Notable Investments == | == Notable Investments == | ||
| In July 2023, Bias Capital led a $25 million ] funding round for ], a biotech company focused on revolutionizing ] and healthcare management.<ref>{{Cite news |title=Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare |url=https://www.businesswire.com/news/home/20230712832557/en/Parker-Health-Secures-25-Million-in-Series-A-Funding-to-Transform-American-Healthcare |archive-url=http://web.archive.org/web/20241005112855/https://www.businesswire.com/news/home/20230712832557/en/Parker-Health-Secures-25-Million-in-Series-A-Funding-to-Transform-American-Healthcare |archive-date=2024-10-05 |access-date=2024-12-13 |language=en}}</ref> | In July 2023, Bias Capital led a $25 million ] funding round for ], a biotech company focused on revolutionizing ] and healthcare management.<ref>{{Cite news |title=Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare |url=https://www.businesswire.com/news/home/20230712832557/en/Parker-Health-Secures-25-Million-in-Series-A-Funding-to-Transform-American-Healthcare |archive-url=http://web.archive.org/web/20241005112855/https://www.businesswire.com/news/home/20230712832557/en/Parker-Health-Secures-25-Million-in-Series-A-Funding-to-Transform-American-Healthcare |archive-date=2024-10-05 |access-date=2024-12-13 |language=en}}</ref> | ||
| {{Uncategorized|date=December 2024}} | |||
| {{Drafts moved from mainspace|date=December 2024}} | {{Drafts moved from mainspace|date=December 2024}} | ||
Revision as of 17:23, 16 December 2024
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
| Company type | Private |
|---|---|
| Industry | Venture capital |
| Founded | February 2021; 3 years ago (2021-02) |
| Founder | Maximillian Naza |
| Headquarters | San Francisco, California, U.S. |
| Products | Investments |
| Website | https://bias.capital/ |
Bias Capital, LLC (commonly known as Bias Capital) is an American venture capital firm that invests in both early-stage start-ups and established growth companies. In addition to its primary investments, the firm operates an angel syndicate, offering individual investors the opportunity to access and participate in select investment opportunities.
The firm was established to integrate diversity as a core principle in its investment strategy and operations. Rather than treating diversity as a separate initiative, Bias Capital incorporates it into all aspects of its decision-making process.
The firm aims to build a portfolio that reflects societal diversity by supporting underrepresented founders and fostering inclusive innovation.
Bias Capital operates as the venture capital arm of PasciVite.
Notable Investments
In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.
References
- "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.